Fluconazole Tarbis 150 mg hard capsules EFG

Spain
Brand name Fluconazole Tarbis 150 mg hard capsules EFG
Form capsules, hard
Active substance / Dosage
FLUCONAZOLE · 150 mg
Prescription type Prescription Only Medicine
Registration number 64335
Manufacturer Tarbis Farma S.L.
Fluconazole Tarbis 150 mg hard capsules EFG capsules, hard

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Fluconazole Tarbis 150 mg hard capsules EFG

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse reactions, talk to your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Leaflet contents:

  1. What Fluconazole Tarbis is and what it is used for.
  2. What you need to know before taking Fluconazole Tarbis.
  3. How to take Fluconazole Tarbis.
  4. Possible side effects.
  5. How to store Fluconazole Tarbis.
  6. Contents of the pack and other information.

1. What Fluconazol Tarbis is and what it is used for

Fluconazol Tarbis is one of the medicines belonging to a group called "antifungals". The active substance is fluconazole.

Fluconazol Tarbis is used to treat fungal infections, and it can also be used to prevent the occurrence of a fungal infection. The most common cause of fungal infections is a yeast called Candida.

Adults

Your doctor may prescribe this medicine to treat the following types of fungal infections:

  • Cryptococcal meningitis – a fungal infection in the brain.
  • Coccidioidomycosis – a disease affecting the bronchopulmonary system.
  • Infections caused by Candida located in the bloodstream, in body organs (e.g. heart, lungs), or in the urinary tract.
  • Mucosal candidiasis – infection affecting the lining of the mouth, throat, or associated with dental prostheses.
  • Genital candidiasis – infection of the vagina or penis.
  • Skin infections – e.g. athlete's foot, ringworm, jock itch, nail infections.

Fluconazol Tarbis may also be prescribed to:

  • Prevent recurrence of cryptococcal meningitis.
  • Prevent recurrence of mucosal infections.
  • Reduce repeated episodes of vaginal Candida infections.
  • Prevent transmission of Candida infections (if your immune system is weakened and not functioning properly).

Children and adolescents (0 to 17 years)

Your doctor may prescribe this medicine to treat the following types of fungal infections:

  • Mucosal candidiasis – infection affecting the lining of the mouth or throat.
  • Infections caused by Candida located in the bloodstream, in body organs (e.g. heart, lungs), or in the urinary tract.
  • Cryptococcal meningitis – a fungal infection in the brain.

Fluconazol Tarbis may also be prescribed to:

  • Prevent transmission of Candida infections (if your immune system is weakened and not functioning properly).
  • Prevent recurrence of cryptococcal meningitis.

2. What you need to know before taking Fluconazol Tarbis

Do not take Fluconazol Tarbis if:

  • You are allergic to fluconazole, to other antifungal medicines you have taken, or to any of the other ingredients of this medicine (listed in section 6). Symptoms may include itching, skin redness, or difficulty breathing.
  • You are taking astemizole or terfenadine (antihistamine medicines used to treat allergies).
  • You are taking cisapride (used to treat stomach discomfort).
  • You are taking pimozide (used to treat mental illnesses).
  • You are taking quinidina (used to treat heart arrhythmias).
  • You are taking erythromycin (an antibiotic used to treat infections).

Warnings and precautions

Talk to your doctor or pharmacist before taking Fluconazol Tarbis if:

  • You have liver or kidney problems.
  • You have a heart condition, including irregular heart rhythm.
  • You have abnormal levels of potassium, calcium, or magnesium in your blood.
  • You develop severe skin reactions (itching, skin redness, or difficulty breathing).
    • if you have ever had a severe skin rash, peeling skin, blisters, and/or mouth sores after taking Fluconazol Tarbis.
    • if the fungal infection does not improve, alternative antifungal treatment may be needed.

Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported during treatment with Fluconazol Tarbis. Stop taking Fluconazol Tarbis and seek immediate medical attention if you notice any symptoms related to these severe skin reactions described in section 4.

Using Fluconazol Tarbis with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

Inform your doctor immediately if you are taking astemizole, terfenadine (an antihistamine for allergies), cisapride (used for stomach discomfort), pimozide (used to treat mental illnesses), quinidine (used to treat heart arrhythmias), or erythromycin (an antibiotic for infections), as these medicines must not be taken together with Fluconazol Tarbis (see section: “Do not take Fluconazol Tarbis if”).

Some medicines may interact with Fluconazol Tarbis.

Make sure your doctor knows if you are taking any of the following medicines:

  • Rifampicin or rifabutin (antibiotics for infections).
  • Alfentanil, fentanyl (used as anesthetics).
  • Amitriptyline, nortriptyline (used as antidepressants).
  • Amphotericin B, voriconazole (antifungals).
  • Medicines that reduce blood clotting (warfarin or similar medicines).
  • Benzodiazepines (midazolam, triazolam, or similar medicines) used to help sleep or for anxiety.
  • Carbamazepine, phenytoin (used to treat seizures).
  • Nifedipine, isradipine, amlodipine, felodipine, and losartan (for hypertension – high blood pressure).
  • Cyclosporine, everolimus, sirolimus, or tacrolimus (to prevent transplant rejection).
  • Cyclophosphamide, vinca alkaloids (vincristine, vinblastine, or similar medicines) used to treat cancer.
  • Halofantrine (used to treat malaria).
  • Statins (atorvastatin, simvastatin, fluvastatin, or similar medicines) used to lower high cholesterol levels.
  • Methadone (used for pain).
  • Celecoxib, flurbiprofen, naproxen, ibuprofen, lornoxicam, meloxicam, diclofenac (Non-Steroidal Anti-Inflammatory Drugs – NSAIDs).
  • Oral contraceptives.
  • Prednisone (a steroid).
  • Zidovudine, also known as AZT; saquinavir (used in HIV-infected patients).
  • Medicines for diabetes, such as chlorpropamide, glyburide, glipizide, or tolbutamide.
  • Theophylline (used to control asthma).
  • Vitamin A (nutritional supplement).

Taking Fluconazol Tarbis with food, drinks, and alcohol

You may take this medicine with or without food.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

If you are planning to become pregnant, it is recommended that you wait one week after a single dose of fluconazole before trying to conceive.

For longer treatment courses with fluconazole, consult your doctor about the need to use appropriate contraceptive methods during treatment, which should be continued for one week after the last dose.

You must not take Fluconazol Tarbis if you are pregnant, think you may be pregnant, plan to become pregnant, or are breastfeeding, unless your doctor has instructed you to do so. If you become pregnant while taking this medicine or within one week after the most recent dose, consult your doctor.

Fluconazole taken during the first or second trimester of pregnancy may increase the risk of spontaneous abortion. Fluconazole taken during the first trimester may increase the risk of congenital abnormalities affecting the heart, bones, and/or muscles.

Cases of babies born with congenital abnormalities affecting the skull, ears, and thigh and elbow bones have been reported in women treated for three months or more with high doses (400–800 mg daily) of fluconazole for coccidioidomycosis. The relationship between fluconazole and these cases is not clear.

Consult your doctor or pharmacist before using any medicine.

Driving and using machines

When driving or operating machinery, bear in mind that dizziness or seizures may occasionally occur.

Fluconazol Tarbis contains lactose

This medicine contains a small amount of lactose (milk sugar). If your doctor has informed you that you have an intolerance to certain sugars, consult with them before taking this medicine.

3. How to take Fluconazole Tarbis

Follow exactly the administration instructions for this medicine as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

The capsules should be swallowed whole with a glass of water. It is best to take your medicine at the same time each day.

The usual dose of this medicine for different types of infections is given below:

Adults

Condition

Dosage

To treat cryptococcal meningitis

400 mg on the first day, followed by 200 mg to 400 mg once daily for 6 to 8 weeks or longer if necessary. The dose may sometimes be increased up to 800 mg

To prevent recurrence of cryptococcal meningitis

200 mg once daily until your doctor advises otherwise

To treat coccidioidomycosis

200 mg to 400 mg once daily for 11 to 24 months or longer if necessary. The dose may sometimes be increased up to 800 mg

To treat systemic fungal infections caused by Candida

800 mg on the first day, followed by 400 mg once daily until your doctor advises otherwise

To treat mucosal fungal infections affecting the lining of the mouth, throat, or associated with dental prostheses

200 mg to 400 mg on the first day, then 100 mg to 200 mg daily until your doctor advises otherwise

To treat mucosal candidiasis – dosage depends on the site of infection

50 mg to 400 mg once daily for 7 to 30 days or until your doctor advises otherwise

To prevent mucosal infections affecting the lining of the mouth and throat

100 mg to 200 mg once daily, or 200 mg three times a week, for as long as the risk of developing an infection persists

To treat genital candidiasis

150 mg as a single dose

To reduce recurrent episodes of vaginal candidiasis

150 mg every third day for a total of 3 doses (day 1, 4, and 7), then once weekly for as long as the risk of developing an infection persists

To treat fungal skin or nail infections

Depending on the site of infection: 50 mg once daily, 150 mg once weekly, or 300 to 400 mg once weekly for 1 to 4 weeks (for athlete's foot, up to 6 weeks may be needed; for nail infections, continue treatment until a healthy nail has grown)

To prevent Candida infection (if your immune system is weakened and not functioning properly)

200 mg to 400 mg once daily for as long as the risk of developing an infection persists

Use in adolescents aged 12 to 17 years

Follow the dose prescribed by your doctor (the adult dose or the pediatric dose).

Use in children up to 11 years of age

The maximum daily dose for children is 400 mg per day.

The dose will be based on the child's weight in kilograms.

Condition

Daily dose

Candidiasis of mucous membranes and throat infections caused by Candida – dosage and duration of treatment depend on the severity of the infection and its location.

3 mg per kg of body weight (on the first day, 6 mg per kg of body weight may be given)

Cryptococcal meningitis or internal fungal infections caused by Candida

6 mg to 12 mg per kg of body weight

To prevent a child from becoming infected with Candida (if their immune system is not functioning properly)

3 mg to 12 mg per kg of body weight

Use in children from 0 to 4 weeks of age

Use in children from 3 to 4 weeks of age:

  • The same dose as described in the table, but administered once every 2 days. The maximum dose is 12 mg per kg of body weight every 48 hours.

Use in children under 2 weeks of age:

  • The same dose as described in the table, but administered once every 3 days. The maximum dose is 12 mg per kg of body weight every 72 hours.

Occasionally, doctors may prescribe doses different from those described. Always follow exactly the administration instructions given by your doctor. Consult your doctor or pharmacist if you have any doubts.

Elderly patients

The usual adult dose, unless you have kidney problems.

Patients with kidney problems

Your doctor may adjust your dose depending on how well your kidneys are functioning.

If you take more Fluconazol Tarbis than you should

Taking too many capsules at once may make you feel unwell. Contact your doctor or the nearest hospital immediately. You may also call the Toxicology Information Service at telephone number 91 562 04 20, indicating the medication and the amount taken. Symptoms of a possible overdose may include hearing, seeing, feeling, or thinking things that are not real (hallucinations and paranoid behavior). It may be appropriate to start symptomatic treatment (including supportive measures and gastric lavage if necessary).

If you forget to take Fluconazol Tarbis

Do not take a double dose to make up for missed doses. If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, do not take the missed dose.

If you stop treatment with Fluconazol Tarbis

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone experiences them.

Some people develop allergic reactions, although serious allergic reactions are rare. If any of the following symptoms occur, inform your doctor immediately:

  • Sudden wheezing, difficulty breathing, or chest tightness.
  • Swelling of the eyelids, face, or lips.
  • Itching all over the body, skin redness, or itchy red spots.
  • Skin rash.
  • Severe skin reactions, such as a blistering rash (this may affect the mouth and tongue).

Fluconazol Tarbis may affect your liver. Signs indicating liver problems include:

  • Tiredness.
  • Loss of appetite.
  • Vomiting.
  • Yellowing of the skin or whites of the eyes (jaundice).

If you experience any of these symptoms, stop taking Fluconazol Tarbis and inform your doctor immediately.

Stop taking Fluconazol Tarbis and seek immediate medical attention if you notice any of the following symptoms:

  • Widespread rash, high body temperature, and swollen lymph nodes (DRESS syndrome or drug hypersensitivity syndrome).

Other adverse effects:

Additionally, if you consider any of the adverse effects you experience to be severe, or if you notice any adverse effects not listed in this leaflet, inform your doctor or pharmacist.

The following are frequent adverse effects affecting 1 to 10 in every 100 patients:

  • Headache.
  • Stomach discomfort, diarrhoea, nausea, vomiting.
  • Elevated blood test results indicating liver function abnormalities.
  • Rash.

The following are uncommon adverse effects affecting 1 to 10 in every 1,000 patients:

  • Reduction in red blood cells, which may cause pale skin, weakness, or difficulty breathing.
  • Decreased appetite.
  • Inability to sleep, numbness.
  • Seizures, dizziness, spinning sensation, tingling, prickling, or numbness, changes in taste sensation.
  • Constipation, indigestion, flatulence, dry mouth.
  • Muscle pain.
  • Liver damage and yellowing of the skin and eyes (jaundice).
  • Hives, blisters (wheals), itching, increased sweating.
  • Tiredness, general feeling of being unwell, fever.

The following are rare adverse effects affecting 1 to 10 in every 10,000 patients:

  • Abnormally low levels of white blood cells (which help fight infections) and blood cells involved in stopping bleeding.
  • Red or purple skin discolouration, which may be due to low platelet counts or other blood cell changes.
  • Changes in blood tests (elevated cholesterol, fat levels).
  • Low potassium levels in blood.
  • Tremors.
  • Abnormal electrocardiogram (ECG), changes in heart rate or rhythm.
  • Liver function failure.
  • Allergic reactions (sometimes severe), including extensive blistering and peeling of the skin, severe allergic reactions, swelling of the lips or face.
  • Hair loss.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if they are possible adverse effects not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: www.notificaRAM.es.

By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Fluconazole Tarbis

This medicine does not require any special storage conditions.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Dispose of empty containers and unused medicines at the SIGRE Point in your pharmacy. If you are unsure, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Fluconazole Tarbis

The active substance is fluconazole.

Each hard capsule contains 150 mg of fluconazole.

The other components (excipients) are:

Capsule contents: monohydrate lactose (lactose), pregelatinized corn starch (corn starch), colloidal hydrated silica, magnesium stearate, sodium lauryl sulfate.

Capsule composition: gelatin, titanium dioxide (E171), and quinoline yellow (E 104).

Appearance of the product and contents of the pack

The capsules have a green body and cap.

Available in packs of 1 and 4 hard capsules, and hospital pack containing 100 hard capsules.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

TARBIS FARMA, S.L.

Gran Vía Carlos III, 94

08028 - Barcelona

Spain

Manufacturer:

Neuraxpharm Pharmaceuticals, S.L

Avda. Barcelona, 69

08970 Sant Joan Despí (Barcelona)

Date of the most recent revision of this leaflet: February 2024

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS): http://www.aemps.gob.es/